Do weight-loss jabs weaken bones? GLP-1 skeletal safety

Do GLP-1 jabs directly damage bone?

Short version: no, not directly. GLP-1 medicines — semaglutide (Wegovy, Ozempic), tirzepatide (Mounjaro) and others — are not thought to "attack" your skeleton the way some drugs harm bone. The bone changes seen in studies are largely an indirect consequence of fast weight loss. When you carry less weight, your bones experience less mechanical loading, and bone naturally adapts by becoming a little less dense. This is the same thing seen after low-calorie dieting and, more dramatically, after weight-loss surgery. In other words, some bone change is a normal accompaniment of large, rapid weight loss rather than a unique toxic effect of the jab.

That is reassuring, but it is not a reason to ignore your bones — especially if you already have osteoporosis, are past the menopause, or are older. The honest position is that the long-term bone story for these newer medicines is still being studied.

What does the UK product information actually say?

This matters because it is the regulated, MHRA-approved information for the medicine — not a headline. The Summary of Product Characteristics (SmPC) for Wegovy 2.4 mg lists hip fracture as a "rare" undesirable effect. It explains that in the large cardiovascular outcomes trial (SELECT):

Two things to hold in mind. First, "rare" is the regulator's own frequency category — it means these events were uncommon in absolute terms. Second, this signal is not a boxed warning or a reason on its own to avoid the medicine; it is information to weigh with your clinician, particularly if you are an older woman or already at risk of fractures. The equivalent information for other GLP-1 products differs, so always read the leaflet that comes with your medicine and ask your pharmacist if anything is unclear.

What the bone-density studies found

A small number of trials have measured bone directly with DEXA scans:

• Semaglutide, 52 weeks (64 participants, mostly postmenopausal women at increased fracture risk): bone density fell modestly at the hip and lower spine compared with placebo, alongside about 6.8 kg of weight loss. The researchers linked the bone change to the weight loss itself.
• Liraglutide, 195 participants: bone density dropped with the drug alone, but when strength exercise was added, bone density was preserved — the combination protected the skeleton while still allowing fat loss.

These are short studies with small numbers, and bone density is only a proxy for fracture risk, so the exact figures matter less than the direction: rapid weight loss can nudge bone density down, and exercise helps offset it.

Who is most at risk?

The bone signal is not evenly spread. Some groups have far more to think about:

• Older adults (roughly 65+), who start with less bone reserve. In a study of over-65s with type 2 diabetes, those starting a GLP-1 medicine had an 11% higher fragility-fracture risk (hazard ratio 1.11) than those on other diabetes drugs.
• Postmenopausal women, who have the highest baseline fracture risk — the Wegovy trial signal was clearest in women.
• Anyone with existing osteoporosis or a previous fragility fracture.
• People losing weight very fast, eating very little, or with low calcium/vitamin D.

If any of these apply to you, that is a reason to plan your weight loss with your GP or specialist — not a reason to avoid a medicine that may be protecting you from diabetes or serious weight-related risk.

How to protect your bones (what actually helps)

The most useful steps overlap almost exactly with protecting muscle:

• Strength and weight-bearing exercise. This is the single best-evidenced way to defend bone during weight loss — the liraglutide trial showed it preserved bone density. See the NHS guide to strength and flexibility exercises.
• Enough calcium and vitamin D. Adequate dietary calcium and vitamin D support bone during any weight loss. Ask your pharmacist or GP whether you need a supplement — the right amount depends on your diet, sunlight exposure and other conditions.
• Enough protein, spread through the day, which protects the muscle that in turn loads and supports your bones.
• Lose weight at a sensible pace and stay active day to day.
• Ask about a DXA (bone density) scan if you are older, postmenopausal, or have risk factors — your clinician can advise whether this is appropriate for you.

A word on the headlines

You may have seen alarming coverage claiming weight-loss jabs "cause osteoporosis." Be cautious: some of that reporting is based on early conference material that has not yet been peer-reviewed, does not separate the drug's effect from the effect of weight loss, and sometimes counts diagnosis codes rather than actual fractures. The stronger, published evidence points to a modest, mostly weight-driven effect that is manageable — not a reason to panic. When in doubt, trust the regulated product information and your clinician over a headline.

Related reading